研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

KIT和致癌突变体的低温电子显微分析揭示了结构致癌可塑性和治疗干预的靶点。

Cryo-EM analyses of KIT and oncogenic mutants reveal structural oncogenic plasticity and a target for therapeutic intervention.

发表日期:2023 Mar 28
作者: Stefan G Krimmer, Nicole Bertoletti, Yoshihisa Suzuki, Luka Katic, Jyotidarsini Mohanty, Sheng Shu, Sangwon Lee, Irit Lax, Wei Mi, Joseph Schlessinger
来源: Cellular & Molecular Immunology

摘要:

受体酪氨酸激酶KIT及其配体干细胞因子(SCF)对造血干细胞、生殖细胞和其他细胞的发育至关重要。一系列人类癌症(如急性髓细胞白血病、胃肠道间质瘤和肥大细胞白血病)都由体细胞获得性KIT突变所驱动。本文报道了采用冷冻电镜(cryo-EM)结构分析技术分析了全长野生型和两个癌变型KIT突变体的结果,结果表明配体结合的KIT双聚体的细胞外结构具有对称性,其中包含了不对称的D5同型接触点,紧贴于细胞质膜上。KIT的突变分析表明D5区域是治疗干预的“关键点”。经过配体敏感的KIT突变体展示了一个更全面稳定的D5不对称构象。一个配体非依赖的KIT突变体则采用由D5介导的接触点构形的“V”形状。SCF与该突变体的结合可以完全恢复野生型KIT双聚体的构形,包括D4同型接触的盐桥形成与SCF诱导的KIT双聚体的其他特征。这些实验揭示了肿瘤性KIT突变体的一个出乎意料的结构可塑性以及D5领域的治疗靶点。
The receptor tyrosine kinase KIT and its ligand stem cell factor (SCF) are required for the development of hematopoietic stem cells, germ cells, and other cells. A variety of human cancers, such as acute myeloid leukemia, gastrointestinal stromal tumor, and mast cell leukemia, are driven by somatic gain-of-function KIT mutations. Here, we report cryo electron microscopy (cryo-EM) structural analyses of full-length wild-type and two oncogenic KIT mutants, which show that the overall symmetric arrangement of the extracellular domain of ligand-occupied KIT dimers contains asymmetric D5 homotypic contacts juxtaposing the plasma membrane. Mutational analysis of KIT reveals in D5 region an "Achilles heel" for therapeutic intervention. A ligand-sensitized oncogenic KIT mutant exhibits a more comprehensive and stable D5 asymmetric conformation. A constitutively active ligand-independent oncogenic KIT mutant adopts a V-shaped conformation solely held by D5-mediated contacts. Binding of SCF to this mutant fully restores the conformation of wild-type KIT dimers, including the formation of salt bridges responsible for D4 homotypic contacts and other hallmarks of SCF-induced KIT dimerization. These experiments reveal an unexpected structural plasticity of oncogenic KIT mutants and a therapeutic target in D5.